Bangkok Dusit Medical Services Share Price
Equities
BDMS
TH0264A10Z04
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.10 THB | +3.08% |
|
+11.05% | +4.15% |
| Capitalization | 32TCr 1.03TCr 876.98Cr 812.56Cr 764.21Cr 1.42TCr 94TCr 1.53TCr 9.38TCr 3.71TCr 45TCr 3.86TCr 3.78TCr 1,62500Cr | P/E ratio 2025 * |
19.5x | P/E ratio 2026 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise value | 32TCr 1.04TCr 885.94Cr 820.86Cr 772.01Cr 1.44TCr 95TCr 1.54TCr 9.48TCr 3.74TCr 45TCr 3.9TCr 3.82TCr 1,64200Cr | EV / Sales 2025 * |
2.87x | EV / Sales 2026 * | 2.75x |
| Free-Float |
65.22% | Yield 2025 * |
3.8% | Yield 2026 * | 4.02% |
| 1 day | +3.08% | ||
| 1 week | +11.05% | ||
| Current month | +4.15% | ||
| 1 month | +2.03% | ||
| 3 months | +1.52% | ||
| 6 months | -6.07% | ||
| Current year | +4.15% |
| 1 week | 17.7 |  | 20.3 |
| 1 month | 17.4 | | 20.3 |
| Current year | 17.4 | | 20.3 |
| 1 year | 17.4 | | 24.9 |
| 3 years | 17.4 | | 31.25 |
| 5 years | 17.4 | | 32 |
| 10 years | 15.6 | | 32 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 23/01/2019 | |
Narumol Noi-Am
DFI | Director of Finance/CFO | 68 | 04/01/2008 |
| Chief Operating Officer | 70 | 23/01/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 91 | 28/04/2021 | |
| Director/Board Member | 93 | 01/01/1994 | |
Narumol Noi-Am
BRD | Director/Board Member | 68 | 23/01/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.08% | +11.05% | -14.83% | -33.55% | 992.71Cr | |
| 0.00% | -1.64% | +17.62% | +40.40% | 1.83TCr | |
| -2.49% | -0.35% | -8.37% | -56.56% | 1.51TCr | |
| -3.09% | -4.90% | +1.94% | +60.08% | 1.13TCr | |
| -0.67% | +0.82% | +28.71% | +92.49% | 1.04TCr | |
| -1.03% | -1.09% | +3.57% | +58.28% | 1.01TCr | |
| -0.78% | -0.39% | -29.28% | - | 780.43Cr | |
| -3.99% | -4.13% | +31.06% | +199.51% | 741.13Cr | |
| +0.08% | +2.06% | +7.41% | -45.85% | 565.87Cr | |
| Average | -0.99% | +1.08% | +4.20% | +39.35% | 1.07TCr | |
| Weighted average by Cap. | -0.98% | +0.64% | +4.67% | +33.99% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 11TCr 362.66Cr 309.09Cr 286.39Cr 269.35Cr 501.35Cr 33TCr 537.79Cr 3.31TCr 1.31TCr 16TCr 1.36TCr 1.33TCr 57TCr | 12TCr 382.31Cr 325.84Cr 301.9Cr 283.94Cr 528.51Cr 35TCr 566.92Cr 3.48TCr 1.38TCr 17TCr 1.43TCr 1.4TCr 60TCr |
| Net income | 1.65TCr 53Cr 45Cr 42Cr 40Cr 74Cr 4.85TCr 79Cr 485.47Cr 191.79Cr 2.3TCr 199.72Cr 195.62Cr 8.41TCr | 1.75TCr 56Cr 48Cr 45Cr 42Cr 78Cr 5.13TCr 84Cr 514.16Cr 203.13Cr 2.44TCr 211.52Cr 207.19Cr 8.91TCr |
| Net Debt | 326.29Cr 11Cr 8.96Cr 8.3Cr 7.81Cr 15Cr 956.57Cr 16Cr 96Cr 38Cr 454.85Cr 39Cr 39Cr 1.66TCr | 727.08Cr 23Cr 20Cr 18Cr 17Cr 32Cr 2.13TCr 35Cr 213.49Cr 84Cr 1.01TCr 88Cr 86Cr 3.7TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | 20.10 ฿ | +3.08% | 15,73,71,300 |
| 19/26/19 | 19.50 ฿ | +3.17% | 9,05,85,320 |
| 16/26/16 | 18.90 ฿ | +2.16% | 5,47,98,520 |
| 15/26/15 | 18.50 ฿ | +2.78% | 5,89,88,920 |
| 14/26/14 | 18.00 ฿ | +2.27% | 9,14,68,820 |
End-of-day quote Thailand S.E., January 20, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BDMS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition